Amarin Corp Plc (AMRN)

[couldbebetter]

MS83, A year ago posters were worried that perhaps AMRN could not produce
enough Vascepa for the US let alone the ROW. If a BP bought us today, it
could plan to make enough Vascepa for Europe and if it lost the appeal,
assuming it gets that far, and no other solution to the generics issue
is found, it could devote all production towards Europe and the ROW.
BP might have "remedies" to the generics issue that AMRN does not have.
BP might have more chips to play with...perhaps negotiating a deal
to allow it a generic launch of some other drug(s) while they allow
BP to build up revenues to optimal levels in the US.

One could argue that if BP could build Vascepa into a much more widely
used drug than what AMRN ever could by itself, it would behoove generics
to want BP to own AMRN as it would mean a far larger market to have
once they do launch a generic. (Could all of this be a ploy to insure
that AMRN end up in BP hands...except that BP will acquire AMRN at a
fraction of its real value?) Hmm.